A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.
about
Current and future pharmacological therapies for NAFLD/NASH.Clinical application of angiotensin receptor blockers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment.
P2860
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
A randomised controlled trial ...... non-alcoholic steatohepatitis.
@ast
A randomised controlled trial ...... non-alcoholic steatohepatitis.
@en
A randomised controlled trial ...... non-alcoholic steatohepatitis.
@nl
type
label
A randomised controlled trial ...... non-alcoholic steatohepatitis.
@ast
A randomised controlled trial ...... non-alcoholic steatohepatitis.
@en
A randomised controlled trial ...... non-alcoholic steatohepatitis.
@nl
prefLabel
A randomised controlled trial ...... non-alcoholic steatohepatitis.
@ast
A randomised controlled trial ...... non-alcoholic steatohepatitis.
@en
A randomised controlled trial ...... non-alcoholic steatohepatitis.
@nl
P2093
P2860
P50
P1433
P1476
A randomised controlled trial ...... non-alcoholic steatohepatitis.
@en
P2093
Alastair D Burt
Christopher P Day
Deborah D Stocken
Derek Mann
Dina Tiniakos
Jane Barnes
Jennifer Wilkinson
Nick Steen
Nicola Goudie
Nina Wilkinson
P2860
P304
P356
10.1371/JOURNAL.PONE.0175717
P407
P577
2017-04-18T00:00:00Z